Dutasteride, cantharidin, atopiclair, cetuximab, sirolimus, AC-11 and dimericine reviewed in brief

Noah Scheinfeld1

  • 1St. Luke's-Roosevelt Hospital Center, New York, NY, USA.

Abstract

No abstract available in PubMed .